申请人:Merck Sharp & Dohme Corp.
公开号:US10072025B2
公开(公告)日:2018-09-11
The instant invention provides compounds of Formula (I) which are JAK inhibitors, and as such are useful for the treatment of JAK-mediated diseases such as rheumatoid arthritis, asthma, COPD and cancer. The present invention provides novel compounds which are inhibitors of JAKs. The invention also provides a method for the treatment and prevention of JAK-mediated diseases and disorders using the novel compounds, as well as pharmaceutical compositions containing the compounds.
本发明提供的式 (I) 化合物是 JAK 抑制剂,因此可用于治疗 JAK 介导的疾病,如类风湿性关节炎、哮喘、慢性阻塞性肺病和癌症。本发明提供了作为 JAK 抑制剂的新型化合物。本发明还提供了一种使用这些新型化合物治疗和预防 JAK 介导的疾病和紊乱的方法,以及含有这些化合物的药物组合物。